Biosimilars

The US FDA Grants Approval to Celltrion's Steqeyma (Biosimilar, Stelara)

The US FDA Grants Approval to Celltrion's Steqeyma (Biosimilar, Stelara)

Shots: Celltrion has receive the US FDA’s approval for Steqeyma, biosimilar...

Bio-Thera Solutions and SteinCares Add Another Biosimilar, Expanding their Alliance

Bio-Thera Solutions and SteinCares Add Another Biosimilar, Expanding their Alliance

Shots: Bio-Thera Solutions has expanded its collaboration with SteinCares, grantin...

Celltrion Secures the CHMP’s Positive Opinion for Eydenzelt (Biosimilar, Eylea), Stoboclo & Osenvelt (Biosimilars, Prolia & Xgeva) and Avtozma (Biosimilar, RoActemra)

Celltrion Secures the CHMP’s Positive Opinion for Eydenzelt (Biosimilar, Eylea), Stoboclo & Osenvelt (Biosimilars, Prolia & Xgeva)...

Shots: The P-III trial of Eydenzelt vs Eylea (aflibercept) in diabetic macular ede...

Celltrion’s Omlyclo (CT-P39) Secures the Health Canada’s Approval (Biosimilar, Xolair)

Celltrion’s Omlyclo (CT-P39) Secures the Health Canada’s Approval (Biosimilar, Xolair)

Shots: The Health Canada has granted approval to Celltrion’s Omlyclo, a bios...

Biocon Biologics Reports the US FDA’s Approval of Yesintek (Biosimilar, Stelara)

Biocon Biologics Reports the US FDA’s Approval of Yesintek (Biosimilar, Stelara)

Shots: The US FDA has granted approval to the company’s Yesintek, a biosimil...

Xbrane Biopharma and Intas Pharmaceuticals Join Forces to Develop Biosimilar of Opdivo (Nivolumab)

Xbrane Biopharma and Intas Pharmaceuticals Join Forces to Develop Biosimilar of Opdivo (Nivolumab)

Shots: Xbrane and Intas have entered into a global licensing and co-development ag...

Image